Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

overall survival

  • Open Access
    Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular Carcinoma
    ERGİN AYDEMİR, FUNDA YILMAZ, ALPER TÜRKEL, ÖZTÜRK ATEŞ and MUTLU DOĞAN
    In Vivo September 2025, 39 (5) 2976-2985; DOI: https://doi.org/10.21873/invivo.14098
  • Open Access
    Prognostic Significance of Inflammation-based Scores in Pancreatic Cancer Patients Treated With Palliative Chemotherapy: A Single Institution Experience
    MARIÁN LIBERKO, TOMÁŠ SYCHRA, MARTIN OLIVERIUS and RENATA SOUMAROVÁ
    In Vivo November 2024, 38 (6) 2782-2794; DOI: https://doi.org/10.21873/invivo.13758
  • Open Access
    Colon Cancer With Bladder Invasion: A Single Center Experience
    TZU-WEI CHIANG, LI-WEN CHANG, FENG-FAN CHIANG, JIAN-RI LI and SHENG-CHUN HUNG
    In Vivo November 2024, 38 (6) 2990-3001; DOI: https://doi.org/10.21873/invivo.13782
  • Open Access
    Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?
    OKSANA ZEMSKOVA, NATHAN Y. YU, JAN LEPPERT, ANASTASSIA LÖSER and DIRK RADES
    In Vivo September 2024, 38 (5) 2341-2348; DOI: https://doi.org/10.21873/invivo.13700
  • Open Access
    Impact of PD-L1 Expression on the Overall Survival of Patients With Non-small Cell Lung Cancer Treated With Single-agent Pembrolizumab
    MARTIN SVATON, MAGDALENA KNETKI-WROBLEWSKA, SYLWIA TABOR, PETR DOMECKY, ONDREJ VENCLICEK, JANA KREJCI, MARIE DROSSLEROVA, MICHAL HRNCIARIK, DANIEL HRICISAK, ALZBETA BEJCKOVA, ONDREJ FISCHER, MARTINA VITKOVA and MACIEJ KRZAKOWSKI
    In Vivo September 2024, 38 (5) 2434-2440; DOI: https://doi.org/10.21873/invivo.13712
  • Open Access
    The Role of Radiotherapy for Meningeal Melanocytomas – A 20 Year Update
    DIRK RADES, OKSANA ZEMSKOVA, JAN GLIEMROTH and NATHAN Y. YU
    In Vivo May 2024, 38 (3) 1220-1228; DOI: https://doi.org/10.21873/invivo.13558
  • Open Access
    Chemotherapy With Eribulin Following Potentially Curative Surgery in Patients With Localized Liposarcoma
    OSKAR STEINBRECHER, THOMAS BRODOWICZ, PETAR POPOV and WOLFGANG LAMM
    In Vivo January 2024, 38 (1) 385-389; DOI: https://doi.org/10.21873/invivo.13450
  • Open Access
    Prognostic Factors of Extramammary Paget’s Disease: A Retrospective Study at a Medical Center in Taiwan
    HSUEH-FEN NI, JIAN-RI LI, SHIAN-SHIANG WANG, SHENG-CHUN HUNG, CHENG-KUANG YANG, CHUAN-SHU CHEN and KUN-YUAN CHIU
    In Vivo November 2023, 37 (6) 2786-2791; DOI: https://doi.org/10.21873/invivo.13390
  • Open Access
    Adjuvant Radiotherapy for Major Salivary Gland Malignancies: Impact on Locoregional Control and Survival Outcomes
    ATSUTO KATANO and HIDEOMI YAMASHITA
    In Vivo November 2023, 37 (6) 2792-2795; DOI: https://doi.org/10.21873/invivo.13391
  • Open Access
    Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)
    SHINICHIRO OKAUCHI, GEN OHARA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, TAKESHI NUMATA, RYOTA NAKAMURA, TOMOHIRO TAMURA, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, HIROFUMI SAKURAI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, TAKEO ENDO, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, HIROAKI SATOH, TORU SAKAMOTO and NOBUYUKI HIZAWA
    In Vivo September 2023, 37 (5) 2203-2209; DOI: https://doi.org/10.21873/invivo.13320

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
In Vivo

© 2026 In Vivo

Powered by HighWire